CaresAI at CT-DEB’26: Detecting Dosing Errors In Clinical Trials Using Domain-Specific Transformer Embeddings and Classification Models
2026
Read CaresAI at CT-DEB’26: Detecting Dosing Errors In Clinical Trials Using Domain-Specific Transformer Embeddings and Classification Models (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2606-30236.txt.
Description
Leon Hamnett, Favour Igwezeke, Joseph Abubakar, and Mary Adewunmi, writing for CaresAI, detect dosing errors in clinical trials from trial text. Medication dosing errors can harm patients and damage trial integrity. Early detection supports safety watch and regulator choices. The team tests whether transformer language models can flag risky trials. Several biomedical encoders compete in their framework.
Trial text is encoded with ClinicalBERT, PubMedBERT, BioBERT, and MedCPT. Categorical trial features join the text codes as inputs. With logistic regression as the yardstick, BioBERT wins among them. Its discrimination score beats the ClinicalBERT baseline by several percent. Combining several embeddings does not help further. Domain alignment matters more than stacking representations, they conclude. Gradient boosting, support vector machines, and residual networks perform best overall. Their scores cluster in a strong band for predicting elevated dosing error risk.
Catalog record
| YEAR | 2026 |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2606.30236